18 sep 2024
Vitafoods Asia 2024


Exhibitor at Vitafoods Asia 2024 stand E35

About us

BIFIDO Co., Ltd. was founded in 1999, in the spirit of challenge to pursue the best biotechnology and be the best in the field of the human microbiome.

Among various intestinal microbiome, Bifidobacterium is considered to be the most beneficial bacterium to maintain healthy intestinal microbial balance. BIFIDO has focused on research and development of Bifidobacterium spp. since 1999. Over 250 related scientific papers and 80 patents prove that BIFIDO is the top-tier company with the greatest experience and expertise in the microbiome industry.

Recently, BIFIDO started microbiome research on rheumatoid arthritis (RA), a chronic inflammatory disease. We analyzed the microbiota of RA patients and tried to find a way to treat even those who were less responsive to treatment. We have selected novel Bifidobacterium strains that can improve the symptoms of RA in animal models, and we expect new pharmabiotics from those strains. We are now expanding our pipelines for other immune-related diseases, including cancer.

Specs about this supplier

Sales markets Asia; Australia; Eastern Europe; Middle East; North America; Western Europe
Affiliated categories: Food Supplements / Nutraceuticals |Functional Food |Nutrients More

Products featured at Vitafoods Asia 2024

Categories affiliated with BIFIDO CO.,LTD.


Event information

Vitafoods Asia 2024

18 - 20 Sept 2024 Bangkok, Thailand Visit us at stand E35